Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Malcolm J. Kavarana is active.

Publication


Featured researches published by Malcolm J. Kavarana.


Annals of the New York Academy of Sciences | 2003

Exploring the Stereostructural Requirements of Peptide Ligands for the Melanocortin Receptors

Victor J. Hruby; Minying Cai; Paolo Grieco; Guoxia Han; Malcolm J. Kavarana; Dev Trivedi

Abstract: The melanotropin peptides α‐MSH, γ‐MSH, and β‐MSH are believed to be the natural ligands for the four melanocortin receptors, MC1R, MC3R, MC4R, and MC5R. However, these peptides generally have low selectivity for these receptors. We report on some approaches to the development of selective agonists and antagonists peptide ligands for these receptors.


Archive | 2001

The Development of a Novel Highly Selective and Potent Agonist for Human Melanocortin 4 Receptor

Malcolm J. Kavarana; Minying Cai; D. Trivedi; Guoxia Han; Victor J. Hruby

α-, β-, and γ-MSH, along with adrenocorticotropic hormones form a group of endogenous neuropeptides that regulate several key biological functions via five melanocortin (MC1R-MC5R) seven transmembrane G-protein coupled receptors (GPCR). Recent studies have indicated that in humans, the MC4R plays an important role in controlling feeding behavior and energy homeostasis [1,2]. These studies have further shown that agonists at hMC4R promote a feeling of satiety, while antagonists induce feeding. Thus selective agonists at this receptor could find therapeutic applications as anti-obesity drugs. This work discusses the development of the first highly selective and potent agonist MK-1 (c[(O)C-CH2-CH2-C(O)-His6-D-Phe7-Arg8-Trp9-Lys10]-NH2), at the human MC4 receptor versus the other three hMCR’s (hMC1, hMC3 and hMC5) respectively.


Archive | 2001

Synthesis of Amino Acids with Novel Biophysical Properties

Zhanna V. Zhilina; Isabel D. Alves; Scott Cowell; Xuejun Tang; Malcolm J. Kavarana; Victor J. Hruby

Amino acids with unique physical properties have been used to study the conformational interactions of peptides and proteins. Two such molecules are pyrenylalanine and ferro-cenylalkyl derivatives of amino acids. Pyrenylalanine has unique spectroscopic properties that can be exploited to understand conformations of peptides [1], Ferrocenylalkyl derivatives of amino acids combine the properties of ferrocene and amino acids to offer compounds that will intercalate with DNA and can be targeted towards cancerous cells [2]. This paper describes the synthesis of these compounds and presents preliminary data concerning the intercalation of the ferrocenylalkyl amino acids towards DNA.


Biochemistry | 1999

Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue.

Alexander D. Cameron; Marianne Ridderström; Birgit Olin; Malcolm J. Kavarana; Donald J. Creighton; Bengt Mannervik


Journal of Medicinal Chemistry | 1999

Mechanism-based competitive inhibitors of glyoxalase I : Intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum

Malcolm J. Kavarana; Elena G. Kovaleva; Donald J. Creighton; Megan B. Wollman; Julie L. Eiseman


Journal of Medicinal Chemistry | 2002

Novel cyclic templates of α-MSH give highly selective and potent antagonists/ agonists for human melanocortin-3/4 receptors

Malcolm J. Kavarana; Der Trivedi; Minying Cai; Jinfa Ying; Matthew R. Hammer; Christopher M. Cabello; Paolo Grieco; Guoxia Han; Victor J. Hruby


Biopolymers | 2003

Solution structures of cyclic melanocortin agonists and antagonists by NMR

Jinfa Ying; Katalin E. Kövér; Xuyuan Gu; Guoxia Han; Dev Trivedi; Malcolm J. Kavarana; Victor J. Hruby


Journal of Medicinal Chemistry | 1994

S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II.

Nunna S.R.K. Murthy; Tina Bakeris; Malcolm J. Kavarana; Diana S. Hamilton; Yin Lan; Donald J. Creighton


Journal of Medicinal Chemistry | 2000

Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I.

Avinash Kalsi; Malcolm J. Kavarana; Tianfen Lu; Dale L. Whalen; Diana S. Hamilton; Donald J. Creighton


Journal of Medicinal Chemistry | 1999

A new method for rapidly generating inhibitors of glyoxalase I inside tumor cells using S-(N-aryl-N-hydroxycarbamoyl)ethylsulfoxides.

Diana S. Hamilton; Malcolm J. Kavarana; Ellyn M. Sharkey; Julie L. Eiseman; Donald J. Creighton

Collaboration


Dive into the Malcolm J. Kavarana's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paolo Grieco

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge